Cytoreductive Surgery and Intraoperative Administration of Paclitaxel-loaded Expansile Nanoparticles Delay Tumor Recurrence in Ovarian Carcinoma

Paclitaxel-Loaded Expansile Nanoparticles in a Multimodal Treatment Model of Malignant Mesothelioma

(2011) Morgan D. Schulz et al.   ANNALS OF THORACIC SURGERY

Folate-targeted nanoparticle delivery of chemo- and radiotherapeutics for the treatment of ovarian cancer peritoneal metastasis

(2011) Michael E. Werner et al.   BIOMATERIALS

A phase II evaluation of nanoparticle, albumin-bound (nab) paclitaxel in the treatment of recurrent or persistent platinum-resistant ovarian, fallopian tube, or primary peritoneal cancer: A Gynecologic Oncology Group Study

(2011) Robert L. Coleman et al.   GYNECOLOGIC ONCOLOGY

In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles

(2011) Brian R. Sloat et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Hydrogels as Intracellular Depots for Drug Delivery

(2011) Kimberly Ann V. Zubris et al.   MOLECULAR PHARMACEUTICS

Nanomedicine

(2010) Betty Y.S. Kim et al.   NEW ENGLAND JOURNAL OF MEDICINE

Expansile Nanoparticles: Synthesis, Characterization, andin VivoEfficacy of an Acid-Responsive Polymeric Drug Delivery System

(2009) Aaron P. Griset et al.   JOURNAL OF THE AMERICAN CHEMICAL SOCIETY

Tumour-targeted nanomedicines: principles and practice

(2008) T Lammers et al.   BRITISH JOURNAL OF CANCER